MCH ADVISORY RESEARCH
Real Estate

Health Care REITs

8 companies under coverage.

Coverage

Health Care REITs


Equity Research

Welltower Inc (WELL)

HOLD. 12-month probability-weighted target $243 (+1% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

WELLEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Ventas Inc (VTR)

HOLD. 12-month probability-weighted target $92 (-2% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

VTREquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Sabra Healthcare REIT Inc (SBRA)

HOLD. 12-month probability-weighted target $20 (-4% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SBRAEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Omega Healthcare Investors Inc (OHI)

HOLD. 12-month probability-weighted target $49 (+6% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

OHIEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Healthcare Realty Trust Incorporated (HR)

HOLD. 12-month probability-weighted target $21 (+10% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HREquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

Healthpeak Properties Inc (DOC)

HOLD. 12-month probability-weighted target $21 (-4% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

DOCEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

CareTrust REIT Inc. (CTRE)

HOLD. 12-month probability-weighted target $42 (+6% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

CTREEquity ResearchMonte Carlo
25 August 2026Rating: HOLD
Equity Research

American Healthcare REIT, Inc. (AHR)

SELL. 12-month probability-weighted target $47 (-16% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AHREquity ResearchMonte Carlo
25 August 2026Rating: SELL
MCH ADVISORY SERVICES · All research · Not investment advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.19.0 · US-listed · UK English